<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:chebi fb="0" ids="6887">Methylphenidate</z:chebi> is a central <z:mp ids='MP_0008912'>nervous</z:mp> system stimulant used for the treatment of <z:hpo ids='HP_0007018'>attention deficit hyperactivity disorder</z:hpo> and <z:mp ids='MP_0005279'>narcolepsy</z:mp> and like other psychostimulants has a potential for abuse </plain></SENT>
<SENT sid="1" pm="."><plain>CASE STUDY: A young man with a cerebral <z:e sem="disease" ids="C0333559" disease_type="Disease or Syndrome" abbrv="">lacunar infarction</z:e> following <z:hpo ids='HP_0011010'>chronic</z:hpo> oral abuse of <z:chebi fb="0" ids="6887">methylphenidate</z:chebi> is presented </plain></SENT>
<SENT sid="2" pm="."><plain>CONCLUSIONS: The experience of our patient and a review of the literature suggest that <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> is a potential side effect of <z:hpo ids='HP_0011010'>chronic</z:hpo> consumption of <z:chebi fb="0" ids="6887">methylphenidate</z:chebi> </plain></SENT>
</text></document>